TETRADOL Trademark
Serial Number: 79408939 • Registration: 8112724
TETRADOL is a trademark filed by
Entomus s.r.o.
on October 16, 2024. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Andrew T. Rissler Patel IP, P.C.
20700 Ventura Blvd. Suite 235
Woodland Hills, CA 91364
United States
Trademark Details
Filing Date
October 16, 2024
Registration Date
January 27, 2026
Published for Opposition
December 9, 2025
Goods & Services
Analgesic medicines for human purposes
Filing History
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 27, 2026 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 23, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 6, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 6, 2026 OPNR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 27, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 27, 2026 R.PR
NOTIFICATION PROCESSED BY IB
Dec 11, 2025 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 9, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 9, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 3, 2025 NONP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 26, 2025 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 25, 2025 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 6, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 6, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 6, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 6, 2025 TROA
REFUSAL PROCESSED BY IB
May 31, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 15, 2025 RFCS
REFUSAL PROCESSED BY MPU
May 15, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 25, 2025 RFCR
NON-FINAL ACTION WRITTEN
Mar 24, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 24, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 8, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 8, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 7, 2024 REPR